(Press-News.org) There are potential legal ramifications for physicians of patients who drive with cognitive impairment, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
Between 20 and 60 percent of patients with cirrhosis (a condition in which the liver is permanently scarred or injured by chronic conditions and diseases) are affected by a peculiar kind of cognitive impairment, also known as hepatic encephalopathy (HE), which can range from mild to overt. This impairment can include cognitive alterations with selective attention, visuomotor ability, psychomotor speed and the ability to suppress behavior. Mild HE has also been associated with an increased number of car accidents and traffic violations.
Doctors studied state requirements for reporting HE, and investigated whether lawsuits have been completed against physicians or patients for motor vehicle accidents that were related to HE.
"We found that hepatic encephalopathy is not specifically addressed in any state vehicle code," said Stanley Martin Cohen, MD, of Loyola University Medical Center and lead author of this study. "In the absence of definite laws, the responsibility for identifying potentially hazardous drivers, and the associated liability, might still lie with the physician." To view Dr. Cohen further discuss his research findings, go to http://www.youtube.com/watch?v=eJdkbQvCE_Y.
Dr. Cohen and colleagues contacted motor vehicle departments from all 50 states and examined motor vehicle codes and legal databases to search for HE-related lawsuits. They found that definitions of a medically impaired driver varied considerably. No state specifically mentioned HE or patients with advanced liver disease.
Only six of the states had mandatory reporting laws for drivers who have medical impairments, and 25 of the remaining 44 states provided legal immunity to physicians for reporting such patients. In addition, there were no completed lawsuits against physicians or patients for motor vehicle accidents associated with driving impairment from HE.
"At minimum, physicians and other health-care workers should carefully evaluate their cirrhotic patients for any degree of hepatic encephalopathy and address driving issues with them," added Dr. Cohen.
HE not only affects driving performance, but it is also associated with a reduced quality of life. Even a single episode of overt HE is accompanied by a persistent cognitive defect. In a second study, researchers found that HE is not a fully reversible condition. They evaluated 106 cirrhotic patients for the presence of mild cognitive deficit using a standardized test battery known as the Psychometric Hepatic Encephalopathy Score (PHES), which includes five different psychometric tests.
"Patients with a history of overt hepatic encephalopathy have a persistent cognitive defect despite normal mental status and, in some cases, even despite normal intelligence, aptitude and personality performance evaluated by the Psychometric Hepatic Encephalopathy Score," said Oliviero Riggio, of the Sapienza University of Rome and lead author of this study. "This suggests that the residual cognitive impairment should be examined by specific tests based on the patients' learning capacity."
At clinical examination, all patients were free of overt HE; a total of 27 out of 106 patients had previously experienced at least one episode of overt HE. Based on PHES, patients without prior overt HE were further characterized as affected by mild HE or completely normal.
Patients who previously experienced episodes of overt HE lost their learning capacity when the PHES battery was repeated. On the contrary, in the patients without previous HE, most of the tests and the PHES significantly improved at the second examination. In the group of 27 patients with previous overt HE, there were 19 patients with mild HE and eight with normal PHES. However, in the eight patients without mild HE in whom complete recovery of overt HE may be thought, the repetition of the tests showed the lack of any learning capacity.
INFORMATION:
For more information on cirrhosis, please read the AGA brochure "Understanding Cirrhosis of the Liver" at http://www.gastro.org/patient-center/digestive-conditions/cirrhosis-of-the-liver.
About the AGA Institute
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org.
About Clinical Gastroenterology and Hepatology
The mission of Clinical Gastroenterology and Hepatology is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology. This monthly peer-reviewed journal includes original articles as well as scholarly reviews, with the goal that all articles published will be immediately relevant to the practice of gastroenterology and hepatology. For more information, visit www.cghjournal.org.
Become an AGA fan on Facebook.
Join our LinkedIn group.
Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.
END
MADISON, WI MARCH 17, 2011 – Nitrous oxide is a potent greenhouse gas and a precursor to compounds that contribute to the destruction of the ozone. Intensively managed, grazed pastures are responsible for an increase in nitrous oxide emissions from grazing animals' excrement. Biochar is potentially a mitigation option for reducing the world's elevated carbon dioxide emissions, since the embodied carbon can be sequestered in the soil. Biochar also has the potential to beneficially alter soil nitrogen transformations.
Laboratory tests have indicated that adding biochar ...
The team of Prof. Dr. Stefan Herlitze, the Chair of the Department of Zoology and Neurobiology at RUB, showed that the diseases broke out in mice if, a week after birth, they eliminated a particular protein in the cerebellum which regulates the influx of ions into nerve cells. "It's the first time that we have gained an insight into the origin of these diseases" said Prof. Herlitze. "We can now start conducting research to develop new therapeutic approaches."
Defective calcium channels as a cause of disease
Various forms of epilepsy, coordination disturbances (ataxias) ...
VIDEO:
Scientists of the Institute for Quantum Optics and Quantum Information (IQOQI) in Innsbruck, Austria, have reached a milestone in the exploration of quantum gas mixtures. In an international first, the...
Click here for more information.
Scientists of the Institute for Quantum Optics and Quantum Information (IQOQI) in Innsbruck, Austria, have reached a milestone in the exploration of quantum gas mixtures. In an international first, the research group led by Rudolf ...
The downtown free bingo site has been bringing in themed promotions throughout the week and today's offers may boost players' balances significantly.
City Bingo started the week with 'Irish Luck', a bingo bonus deal that gives the three biggest spenders at the site a cash reward. GBP100, GBP50 and GBP25 will be paid out until the end of the week to the three players depositing the largest amount of funds. These prizes could well be in addition to any bingo wins that users have enjoyed.
Today represents perhaps the best opportunity for City Bingo players to win big ...
DNA contains all of the genetic instructions that make us who we are, and maintaining the integrity of our DNA over the course of a lifetime is a critical, yet complex part of the aging process. In an important, albeit early step forward, scientists have discovered how DNA maintenance is regulated, opening the door to interventions that may enhance the body's natural preservation of genetic information.
The new findings may help researchers delay the onset of aging and aging-related diseases by curbing the loss or damage of our genetic makeup, which makes us more susceptible ...
Clostridium difficile is a health problem that affects hundreds of thousands of patients and costs $10 billion to $20 billion every year in North America. Researchers from the University of Calgary and the National Research Council of Canada say they are gaining a deeper understanding of this disease and are closer to developing a novel treatment using antibodies from llamas.
"We have found that relatively simple antibodies can interfere with the disease-causing toxins from C. difficile," says paper co-author Dr. Kenneth Ng, an associate professor of biological sciences ...
INDIANAPOLIS – A new study, conducted by researchers from the Regenstrief Institute and the schools of medicine at Indiana University and Moi University, is one of the first to explore and demonstrate the impact of electronic record systems on quality of medical care in a developing country.
In a paper published in the March 2011 issue of the Journal of the American Medical Informatics Association, Martin Chieng Were, M.D., M.S., assistant professor of medicine at the IU School of Medicine and a Regenstrief Institute investigator, and colleagues report that computer-generated ...
March 18, 2011, Saskatoon, Saskatchewan — Canada is delivering on its commitment to help the world's most vulnerable, thanks to new developments which will provide an affordable, reliable, and stable treatment for malaria that will save millions of lives, especially those of women and children in Africa. The Honourable Gary Goodyear, Minister of State for Science and Technology, along with Mr. Brad Trost, Member of Parliament for Saskatoon–Humboldt, announced the breakthrough today and highlighted the Government's research support.
"Our government is committed to improving ...
While most bacteria are beneficial to our health -- helping us digest food or fight diseases -- there are a few bacteria, if left untreated, that can be extremely harmful to humans, even to the point of causing death. Bacteria are living single-celled organisms that have the ability to reproduce very quickly and are generally treated easily with antibiotics. Therefore, it is imperative to treat a bacterial infection right away.
Delayed diagnosis of a bacterial infection may have damaging consequences on your health; this is especially true with particularly potent bacteria ...
Scientists have discovered a protein secreted by tuberculosis (TB) bacteria that could be a promising new vaccine candidate, they report today in Proceedings of the National Academy of Sciences. The protein could also be used to improve diagnosis of TB.
TB is caused by the bacterium Mycobacterium tuberculosis (MTB), which infects the lungs and spreads through the air as a result of coughing. There are 9 million new cases of TB each year, killing 4,700 people a day worldwide.
BCG is the only available vaccine but it is of limited effectiveness in protecting against TB. ...
